40 results on '"Bedford, Mark T."'
Search Results
2. Targeting of CYP2E1 by miRNAs in alcohol-induced intestine injury.
- Author
-
Hyejin Mun, Sungyul Lee, Suyoung Choi, Ji-Hoon Jeong, Seungbeom Ko, Yoo Lim Chun, Deaton, Benjamin, Yeager, Clay T., Boyette, Audrey, Palmera, Juliana, Newman, London, Ping Zhou, Soona Shin, Dong-Chan Kim, Sagum, Cari A., Bedford, Mark T., Young-Kook Kim, Jaeyul Kwon, Junyang Jung, and Jeong Ho Chang
- Abstract
Although binge alcohol-induced gut leakage has been studied extensively in the context of reactive oxygen species-mediated signaling, it was recently revealed that post-transcriptional regulation plays an essential role as well. Ethanol (EtOH)-inducible cytochrome P450-2E1 (CYP2E1), a key enzyme in EtOH metabolism, promotes alcohol-induced hepatic steatosis and inflammatory liver disease, at least in part by mediating changes in intestinal permeability. For instance, gut leakage and elevated intestinal permeability to endotoxins have been shown to be regulated by enhancing CYP2E1 mRNA and CYP2E1 protein levels. Although it is understood that EtOH promotes CYP2E1 induction and activation, the mechanisms that regulate CYP2E1 expression in the context of intestinal damage remain poorly defined. Specific miRNAs, including miR-132, miR-212, miR-378, and miR-552, have been shown to repress the expression of CYP2E1, suggesting that these miRNAs contribute to EtOH-induced intestinal injury. Here, we have shown that CYP2E1 expression is regulated post-transcriptionally through miRNA-mediated degradation, as follows: (1) the RNA-binding protein AUbinding factor 1 (AUF1) binds mature miRNAs, including CYP2E1-targeting miRNAs, and this binding modulates the degradation of corresponding target mRNAs upon EtOH treatment; (2) the serine/threonine kinase mammalian Ste20-like kinase 1 (MST1) mediates oxidative stress-induced phosphorylation of AUF1. Those findings suggest that reactive oxygen species-mediated signaling modulates AUF1/miRNA interaction through MST1-mediated phosphorylation. Thus, our study demonstrates the critical functions of AUF1 phosphorylation by MST1 in the decay of miRNAs targeting CYP2E1, the stabilization of CYP2E1 mRNA in the presence of EtOH, and the relationship of this pathway to subsequent intestinal injury. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Histone arginine methylation
- Author
-
Di Lorenzo, Alessandra and Bedford, Mark T.
- Published
- 2011
- Full Text
- View/download PDF
4. SART3 reads methylarginine-marked glycine- and arginine-rich motifs.
- Author
-
Wang, Yalong, Zhou, Jujun, He, Wei, Fu, Rongjie, Shi, Leilei, Dang, Ngoc Khoi, Liu, Bin, Xu, Han, Cheng, Xiaodong, and Bedford, Mark T.
- Abstract
Glycine- and arginine-rich (GAR) motifs, commonly found in RNA-binding and -processing proteins, can be symmetrically (SDMA) or asymmetrically (ADMA) dimethylated at the arginine residue by protein arginine methyltransferases. Arginine-methylated protein motifs are usually read by Tudor domain-containing proteins. Here, using a GFP-Trap, we identify a non-Tudor domain protein, squamous cell carcinoma antigen recognized by T cells 3 (SART3), as a reader for SDMA-marked GAR motifs. Structural analysis and mutagenesis of SART3 show that aromatic residues lining a groove between two adjacent aromatic-rich half-a-tetratricopeptide (HAT) repeat domains are essential for SART3 to recognize and bind to SDMA-marked GAR motif peptides, as well as for the interaction between SART3 and the GAR-motif-containing proteins fibrillarin and coilin. Further, we show that the loss of this reader ability affects RNA splicing. Overall, our findings broaden the range of potential SDMA readers to include HAT domains. [Display omitted] • SART3 is a methylarginine reader • The HAT repeat domain of SART3 harbors reader function • Reader activity is implicated in the regulation of RNA splicing Using a composite arginine methylation substrate, Wang et al. identify SART3 as a "reader" of symmetrically dimethylated arginine (SDMA) motifs. This binding is mediated by a groove formed between two adjacent aromatic-rich half-a-tetratricopeptide (HAT) repeat domains. The integrity of this methyl-dependent interaction is required for normal splicing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)
- Author
-
Orr-Urtreger, Avi, Bedford, Mark T., Burakova, Tatjana, Arman, Esther, Zimmer, Yitzhak, Yayon, Avner, Givol, David, and Lonai, Peter
- Subjects
Fibroblast growth factors -- Analysis ,Mice -- Genetic aspects ,Ligand binding (Biochemistry) -- Observations ,Biological sciences - Abstract
A study of fibroblast growth factor receptor (FGFR) variants in the mouse embryo determined for FGFR-2 that encodes two splice variants called bek and keratinocyte growth factor (KGFR). The binding specificity of bek and KGFR were linked with several FGF. Ligand binding and spatial specificity are caused by alternative splicing, because KGFR and bek have common potential areas of trans regulation in the genome. The expression of both variants is consistent with their role in murine gastrulation.
- Published
- 1993
6. The Arginine Methyltransferase PRMT6 Regulates DNA Methylation and Contributes to Global DNA Hypomethylation in Cancer.
- Author
-
Veland, Nicolas, Hardikar, Swanand, Yi Zhong, Gayatri, Sitaram, Dan, Jiameng, Strahl, Brian D., Rothbart, Scott B., Bedford, Mark T., and Taiping Chen
- Abstract
DNA methylation plays crucial roles in chromatin structure and gene expression. Aberrant DNA methylation patterns, including global hypomethylation and regional hypermethylation, are associated with cancer and implicated in oncogenic events. How DNA methylation is regulated in developmental and cellular processes and dysregulated in cancer is poorly understood. Here, we show that PRMT6, a protein arginine methyltransferase responsible for asymmetric dimethylation of histone H3 arginine 2 (H3R2me2a), negatively regulates DNA methylation and that PRMT6 upregulation contributes to global DNA hypomethylation in cancer. Mechanistically, PRMT6 overexpression impairs chromatin association of UHRF1, an accessory factor of DNMT1, resulting in passive DNA demethylation. The effect is likely due to elevated H3R2me2a, which inhibits the interaction between UHRF1 and histone H3. Our work identifies a mechanistic link between protein arginine methylation and DNA methylation, which is disrupted in cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
7. CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth.
- Author
-
Yin, Shasha, Liu, Liu, Ball, Lauren E., Wang, Yalong, Bedford, Mark T., Duncan, Stephen A., Wang, Haizhen, and Gan, Wenjian
- Abstract
The mammalian target of rapamycin complex1 (mTORC1) is a central regulator of metabolism and cell growth by sensing diverse environmental signals, including amino acids. The GATOR2 complex is a key component linking amino acid signals to mTORC1. Here, we identify protein arginine methyltransferase 1 (PRMT1) as a critical regulator of GATOR2. In response to amino acids, cyclin-dependent kinase 5 (CDK5) phosphorylates PRMT1 at S307 to promote PRMT1 translocation from nucleus to cytoplasm and lysosome, which in turn methylates WDR24, an essential component of GATOR2, to activate the mTORC1 pathway. Disruption of the CDK5-PRMT1-WDR24 axis suppresses hepatocellular carcinoma (HCC) cell proliferation and xenograft tumor growth. High PRMT1 protein expression is associated with elevated mTORC1 signaling in patients with HCC. Thus, our study dissects a phosphorylation- and arginine methylation-dependent regulatory mechanism of mTORC1 activation and tumor growth and provides a molecular basis to target this pathway for cancer therapy. [Display omitted] • PRMT1 is required for amino-acid-induced mTORC1 activation • CDK5 phosphorylates PRMT1 to promote its cytoplasmic localization and activity • PRMT1 methylates WDR24 to promote mTORC1 activation by amino acids • The CDK5-PRMT1-WDR24 axis is critical for cell proliferation and tumor growth Yin et al. find that CDK5 serves as an upstream kinase and WDR24 acts as a downstream target of PRMT1 to promote mTORC1 pathway activation in response to amino acids. They further show that disruption of CDK5, PRMT1, and WDR24 suppresses tumor growth, implicating their therapeutic potential. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. CARM1 arginine methyltransferase as a therapeutic target for cancer.
- Author
-
Santos, Margarida, Jee Won Hwang, and Bedford, Mark T.
- Subjects
- *
PROTEIN arginine methyltransferases , *TRANSCRIPTION factors , *MYC oncogenes , *DRUG development , *DRUG therapy , *EMBRYOLOGY - Abstract
Coactivator-associated arginine methyltransferase 1 (CARM1) is an arginine methyltransferase that posttranslationally modifies proteins that regulate multiple levels of RNA production and processing. Its substrates include histones, transcription factors, coregulators of transcription, and splicing factors. CARM1 is overexpressed in many different cancer types, and often promotes transcription factor programs that are co-opted as drivers of the transformed cell state, a process known as transcription factor addiction. Targeting these oncogenic transcription factor pathways is difficult but could be addressed by removing the activity of the key coactivators on which they rely. CARM1 is ubiquitously expressed, and its KO is less detrimental in embryonic development than deletion of the arginine methyltransferases protein arginine methyltransferase 1 and protein arginine methyltransferase 5, suggesting that therapeutic targeting of CARM1 may be well tolerated. Here, we will summarize the normal in vivo functions of CARM1 that have been gleaned from mouse studies, expand on the transcriptional pathways that are regulated by CARM1, and finally highlight recent studies that have identified oncogenic properties of CARM1 in different biological settings. This review is meant to kindle an interest in the development of human drug therapies targeting CARM1, as there are currently no CARM1 inhibitors available for use in clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Readers of histone methylarginine marks.
- Author
-
Gayatri, Sitaram and Bedford, Mark T.
- Abstract
Arginine methylation is a common posttranslational modification (PTM) that alters roughly 0.5% of all arginine residues in the cells. There are three types of arginine methylation: monomethylarginine (MMA), asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA). These three PTMs are enriched on RNA-binding proteins and on histones, and also impact signal transduction cascades. To date, over thirty arginine methylation sites have been cataloged on the different core histones. These modifications alter protein structure, impact interactions with DNA, and also generate docking sites for effector molecules. The primary "readers" of methylarginine marks are Tudor domain-containing proteins. The complete family of thirty-six Tudor domain-containing proteins has yet to be fully characterized, but at least ten bind methyllysine motifs and eight bind methylarginine motifs. In this review, we will highlight the biological roles of the Tudor domains that interact with arginine methylated motifs, and also address other types of interactions that are regulated by these particular PTMs. This article is part of a Special Issue entitled: Molecular mechanisms of histone modification function. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
10. Assessing kinetics and recruitment of DNA repair factors using high content screens.
- Author
-
Martinez-Pastor, Barbara, Silveira, Giorgia G., Clarke, Thomas L., Chung, Dudley, Gu, Yuchao, Cosentino, Claudia, Davidow, Lance S., Mata, Gadea, Hassanieh, Sylvana, Salsman, Jayme, Ciccia, Alberto, Bae, Narkhyun, Bedford, Mark T., Megias, Diego, Rubin, Lee L., Efeyan, Alejo, Dellaire, Graham, and Mostoslavsky, Raul
- Abstract
Repair of genetic damage is coordinated in the context of chromatin, so cells dynamically modulate accessibility at DNA breaks for the recruitment of DNA damage response (DDR) factors. The identification of chromatin factors with roles in DDR has mostly relied on loss-of-function screens while lacking robust high-throughput systems to study DNA repair. In this study, we have developed two high-throughput systems that allow the study of DNA repair kinetics and the recruitment of factors to double-strand breaks in a 384-well plate format. Using a customized gain-of-function open-reading frame library ("ChromORFeome" library), we identify chromatin factors with putative roles in the DDR. Among these, we find the PHF20 factor is excluded from DNA breaks, affecting DNA repair by competing with 53BP1 recruitment. Adaptable for genetic perturbations, small-molecule screens, and large-scale analysis of DNA repair, these resources can aid our understanding and manipulation of DNA repair. [Display omitted] • Two high-throughput, imaging-based, DNA repair platforms are developed • Machine learning identifies chromatin genes modulating kinetics of DNA repair • HT laser microirradiation uncovers factors recruited and excluded from DNA lesions • PHF20 is actively removed from DNA breaks to allow 53BP1 recruitment and repair Martinez-Pastor et al. developed two imaging-based screening platforms for the study of DNA repair kinetics and recruitment of proteins to damaged chromatin. They tested them against an ORF library of chromatin factors and identify PHF20 as a factor excluded from DNA lesions to allow recruitment of 53BP1 and DNA repair. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Protein methylation and DNA repair
- Author
-
Lake, Aimee N. and Bedford, Mark T.
- Subjects
- *
DNA , *DNA damage , *DNA repair , *POST-translational modification - Abstract
Abstract: DNA is under constant attack from intracellular and external mutagens. Sites of DNA damage need to be pinpointed so that the DNA repair machinery can be mobilized to the proper location. The identification of damaged sites, recruitment of repair factors, and assembly of repair “factories” is orchestrated by posttranslational modifications (PTMs). These PTMs include phosphorylation, ubiquitination, sumoylation, acetylation, and methylation. Here we discuss recent data surrounding the roles of arginine and lysine methylation in DNA repair processes. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
12. Screening for histone codebreakers.
- Author
-
Bedford, Mark T.
- Subjects
- *
METHYLTRANSFERASES , *HISTONES , *DNA methylation , *GENE expression , *GENETIC regulation , *PROTEINS - Abstract
The lysine methyltransferase NSD2 is overexpressed and carries gain-of-function mutations in a number of different cancers, making it an attractive therapeutic target. However, no specific small molecule inhibitors have been identified for this enzyme, responsible for depositing the H3K36me2 mark on histones. A new study reports a robust platform for high-throughput screening (HTS) assays to facilitate this discovery. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. The FF domain: a novel motif that often accompanies WW domains.
- Author
-
Bedford, Mark T. and Leder, Phillip
- Subjects
- *
PROTEINS , *RNA splicing - Abstract
Provides information on a study of proteins that contains single or multiple copies of the FF domain. Requirements of splicing; Effect of the association of different sets of proteins with nascent RNA in a temporarily specific fashion; Components of the yeast and mammalian spliceosome structures.
- Published
- 1999
- Full Text
- View/download PDF
14. A complete methyl-lysine binding aromatic cage constructed by two domains of PHF2.
- Author
-
Horton, John R., Jujun Zhou, Qin Chen, Xing Zhang, Bedford, Mark T., and Xiaodong Cheng
- Subjects
- *
AMINO acid sequence , *PEPTIDES , *X-ray crystallography - Abstract
The N-terminal half of PHF2 harbors both a plant homeodomain (PHD) and a Jumonji domain. The PHD recognizes both histone H3 trimethylated at lysine 4 and methylated nonhistone proteins including vaccinia-related kinase 1 (VRK1). The Jumonji domain erases the repressive dimethylation mark from histone H3 lysine 9 (H3K9me2) at select promoters. The N-terminal amino acid sequences of H3 (AR2TK4) and VRK1 (PR2VK4) bear an arginine at position 2 and lysine at position 4. Here, we show that the PHF2 N-terminal half binds to H3 and VRK1 peptides containing K4me3, with dissociation constants (KD values) of 160 nM and 42 nM, respectively, which are 4 × and 21 × lower (and higher affinities) than for the isolated PHD domain of PHF2. X-ray crystallography revealed that the K4me3-containing peptide is positioned within the PHD and Jumonji interface, with the positively charged R2 residue engaging acidic residues of the PHD and Jumonji domains and with the K4me3 moiety encircled by aromatic residues from both domains. We suggest that the micromolar binding affinities commonly observed for isolated methyllysine reader domains could be improved via additional functional interactions within the same polypeptide or its binding partners. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Methyl-lysine readers PHF20 and PHF20L1 define two distinct gene expression-regulating NSL complexes.
- Author
-
Van, Hieu T., Harkins, Peter R., Patel, Avni, Jain, Abhinav K., Yue Lu, Bedford, Mark T., and Santos, Margarida A.
- Subjects
- *
HISTONE acetyltransferase , *HOMEOBOX proteins , *GENE expression , *CARRIER proteins , *CELL physiology - Abstract
The methyl-lysine readers plant homeodomain finger protein 20 (PHF20) and its homolog PHF20-like protein 1 (PHF20L1) are known components of the nonspecific lethal (NSL) complex that regulates gene expression through its histone acetyltransferase activity. In the current model, both PHF homologs coexist in the same NSL complex, although this was not formally tested; nor have the functions of PHF20 and PHF20L1 regarding NSL complex integrity and transcriptional regulation been investigated. Here, we perform an in-depth biochemical and functional characterization of PHF20 and PHF20L1 in the context of the NSL complex. Using mass spectrometry, genome-wide chromatin analysis, and proteindomain mapping, we identify the existence of two distinct NSL complexes that exclusively contain either PHF20 or PHF20L1. We show that the C-terminal domains of PHF20 and PHF20L1 are essential for complex formation with NSL, and the Tudor 2 domains are required for chromatin binding. The genome-wide chromatin landscape of PHF20-PHF20L1 shows that these proteins bind mostly to the same genomic regions, at promoters of highly expressed/housekeeping genes. Yet, deletion of PHF20 and PHF20L1 does not abrogate gene expression or impact the recruitment of the NSL complex to those target gene promoters, suggesting the existence of an alternative mechanism that compensates for the transcription of genes whose sustained expression is important for critical cellular functions. This work shifts the current paradigm and lays the foundation for studies on the differential roles of PHF20 and PHF20L1 in regulating NSL complex activity in physiological and diseases states. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Dynamics of Human Protein Arginine Methyltransferase 1 (PRMT1) in Vivo.
- Author
-
Herrmann, Frank, Lees, Jaeho, Bedford, Mark T., and Fackelmayer, Frank O.
- Subjects
- *
ARGININE , *METHYLTRANSFERASES , *AMINO acids , *CYTOPLASM , *PROTOPLASM , *TRANSFERASES , *METHYLATION - Abstract
Arginine methylation is a posttranslational protein modification catalyzed by a family of protein arginine methyltransferases (PRMT), the predominant member of which is PRMT1. Despite its major role in arginine methylation of nuclear proteins, surprisingly little is known about the subcellular localization and dynamics of PRMT1. We show here that only a fraction of PRMT1 is located in the nucleus, but the protein is predominantly cytoplasmic. Fluorescence recovery after photobleaching experiments reveal that PRMT1 is highly mobile both in the cytoplasm and the nucleus. However, inhibition of methylation leads to a significant nuclear accumulation of PRMT1, concomitant with the appearance of an immobile fraction of the protein in the nucleus, but not the cytoplasm. Both the accumulation and immobility of PRMT1 is reversed when re-methylation is allowed, suggesting a mechanism where PRMT1 is trapped by unmethylated substrates such as core histones and heterogeneous nuclear ribonucleoprotein proteins until it has executed the methylation reaction. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
17. Genetic evidence for partial redundancy between the arginine methyltransferases CARM1 and PRMT6.
- Author
-
Donghang Cheng, Guozhen Gao, Di Lorenzo, Alessandra, Jayne, Sandrine, Hottiger, Michael O., Richard, Stephane, and Bedford, Mark T.
- Subjects
- *
PROTEIN arginine methyltransferases , *ARGININE , *KNOCKOUT mice , *DNA damage , *CELL proliferation - Abstract
CARM1 is a protein arginine methyltransferase (PRMT) that acts as a coactivator in a number of transcriptional programs. CARM1 orchestrates this coactivator activity in part by depositing the H3R17me2a histone mark in the vicinity of gene promoters that it regulates. However, the gross levels of H3R17me2a in CARM1 KO mice did not significantly decrease, indicating that other PRMT(s) may compensate for this loss. We thus performed a screen of type I PRMTs, which revealed that PRMT6 can also deposit the H3R17me2a mark in vitro. CARM1 knockout mice are perinatally lethal and display a reduced fetal size, whereas PRMT6 null mice are viable, which permits the generation of double knockouts. Embryos that are null for both CARM1 and PRMT6 are noticeably smaller than CARM1 null embryos, providing in vivo evidence of redundancy. Mouse embryonic fibroblasts (MEFs) from the double knockout embryos display an absence of the H3R17me2a mark during mitosis and increased signs of DNA damage. Moreover, using the combination of CARM1 and PRMT6 inhibitors suppresses the cell proliferation of WT MEFs, suggesting a synergistic effect between CARM1 and PRMT6 inhibitions. These studies provide direct evidence that PRMT6 also deposits the H3R17me2a mark and acts redundantly with CARM1. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9.
- Author
-
Hamidi, Tewfik, Singh, Anup Kumar, Veland, Nicolas, Vemulapalli, Vidyasiri, Jianji Chen, Hardikar, Swanand, Bao, Jianqiang, Fry, Christopher J., Vicky Yang, Lee, Kimberly A., Ailan Guo, Arrowsmith, Cheryl H., Bedford, Mark T., and Taiping Chen
- Subjects
- *
HISTONE methyltransferases , *RIBOSOMAL proteins , *METHYLATION , *NONHISTONE chromosomal proteins , *PROTEIN synthesis - Abstract
Set7/9 (also known as Set7, Set9, Setd7, and Kmt7) is a lysine methyltransferase that catalyzes the methylation of multiple substrates, including histone H3 and non-histone proteins. Although not essential for normal development and physiology, Set7/9-mediated methylation events play important roles in regulating cellular pathways involved in various human diseases, making Set7/9 a promising therapeutic target. Multiple Set7/9 inhibitors have been developed, which exhibit varying degrees of potency and selectivity in vitro. However, validation of these compounds in vivo has been hampered by the lack of a reliable cellular biomarker for Set7/9 activity. Here, we report the identification of Rpl29, a ribosomal protein abundantly expressed in all cell types, as a major substrate of Set7/9. We show that Rpl29 lysine 5 (Rpl29K5) is methylated exclusively by Set7/9 and can be demethylated by Lsd1 (also known as Kdm1a). Rpl29 is not a core component of the ribosome translational machinery and plays a regulatory role in translation efficiency. Our results indicate that Rpl29 methylation has no effect on global protein synthesis but affects Rpl29 subcellular localization. Using an Rpl29 methylation-specific antibody, we demonstrate that Rpl29K5 methylation is present ubiquitously and validate that (R)-PFI-2, a Set7/9 inhibitor, efficiently reduces Rpl29K5 methylation in cell lines. Thus, Rpl29 methylation can serve as a specific cellular biomarker for measuring Set7/9 activity. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1.
- Author
-
Narkhyun Bae, Min Gao, Xu Li, Premkumar, Tolkappiyan, Sbardella, Gianluca, Junjie Chen, and Bedford, Mark T.
- Subjects
- *
GENE regulatory networks , *EMBRYOLOGY , *GENETIC transcription , *HISTONE methylation , *CYTOKINE genetics - Abstract
Spindlin1 (SPIN1) is a transcriptional coactivator with critical functions in embryonic development and emerging roles in cancer. SPIN1 harbors three Tudor domains, two of which engage the tail of histone H3 by reading the H3-Lys-4 trimethylation and H3-Arg-8 asymmetric dimethylation marks. To gain mechanistic insight into how SPIN1 functions as a transcriptional coactivator, here we purified its interacting proteins. We identified an uncharacterized protein (C11orf84), which we renamed SPIN1 docking protein (SPIN·DOC), that directly binds SPIN1 and strongly disrupts its histone methylation reading ability, causing it to disassociate from chromatin. The Spindlin family of coactivators has five related members (SPIN1, 2A, 2B, 3, and 4), and we found that all of them bind SPIN·DOC. It has been reported previously that SPIN1 regulates gene expression in the Wnt signaling pathway by directly interacting with transcription factor 4 (TCF4). We observed here that SPIN·DOC associates with TCF4 in a SPIN1-dependent manner and dampens SPIN1 coactivator activity in TOPflash reporter assays. Furthermore, knockdown and overexpression experiments indicated that SPIN.DOC represses the expression of a number of SPIN1- regulated genes, including those encoding ribosomalRNAand the cytokine IL1B. In conclusion, we have identified SPIN·DOC as a transcriptional repressor that binds SPIN1 and masks its ability to engage the H3-Lys-4 trimethylation activation mark. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
20. Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation.
- Author
-
Gates, Leah A., Jiejun Shi, Rohira, Aarti D., Qin Feng, Bokai Zhu, Bedford, Mark T., Sagum, Cari A., Sung Yun Jung, Jun Qin, Ming-Jer Tsai, Tsai, Sophia Y., Wei Li, Foulds, Charles E., and O'Malley, Bert W.
- Subjects
- *
ACETYLATION , *HISTONES , *ELONGATION factors (Biochemistry) , *GENETIC transcription , *CHROMATIN - Abstract
The transition from transcription initiation to elongation is a key regulatory step in gene expression, which requires RNA polymerase II (pol II) to escape promoter proximal pausing on chromatin. Although elongation factors promote pause release leading to transcription elongation, the role of epigenetic modifications during this critical transition step is poorly understood. Two histone marks on histone H3, lysine 4 trimethylation (H3K4me3) and lysine 9 acetylation (H3K9ac), co-localize on active gene promoters and are associated with active transcription. H3K4me3 can promote transcription initiation, yet the functional role of H3K9ac is much less understood. We hypothesized that H3K9ac may function downstream of transcription initiation by recruiting proteins important for the next step of transcription. Here, we describe a functional role for H3K9ac in promoting pol II pause release by directly recruiting the super elongation complex (SEC) to chromatin. H3K9ac serves as a substrate for direct binding of the SEC, as does acetylation of histone H4 lysine 5 to a lesser extent. Furthermore, lysine 9 on histone H3 is necessary for maximal pol II pause release through SEC action, and loss of H3K9ac increases the pol II pausing index on a subset of genes in HeLa cells. At select gene promoters, H3K9ac loss or SEC depletion reduces gene expression and increases paused pol II occupancy.Wetherefore propose that an ordered histone code can promote progression through the transcription cycle, providing new mechanistic insight indicating that SEC recruitment to certain acetylated histones on a subset of genes stimulates the subsequent release of paused pol II needed for transcription elongation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch.
- Author
-
Espejo, Alexsandra B., Gao, Guozhen, Black, Karynne, Gayatri, Sitaram, Veland, Nicolas, Kim, Jeesun, Taiping Chen, Sudol, Marius, Walker, Cheryl, and Bedford, Mark T.
- Subjects
- *
GLUCOCORTICOIDS , *PHOSPHORYLATION , *CHEMICAL reactions , *C-terminal residues , *MAMMALIAN cell cycle , *POST-translational modification - Abstract
PRMT5 is the primary enzyme responsible for the deposition of the symmetric dimethylarginine in mammalian cells. In an effort to understand how PRMT5 is regulated, we identified a threonine phosphorylation site within a C-terminal tail motif, which is targeted by the Akt/serum- and glucocorticoid-inducible kinases. While investigating the function of this posttranslational modification, we serendipitously discovered that its free C-terminal tail binds PDZ domains (when unphosphorylated) and 14-3-3 proteins (when phosphorylated). In essence, a phosphorylation event within the last few residues of the C-terminal tail generates a posttranslational modification-dependent PDZ/14-3-3 interaction "switch." The C-terminal motif of PRMT5 is required for plasma membrane association, and loss of this switching capacity is not compatible with life. This signaling phenomenon was recently reported for theHPVE6 oncoprotein but has not yet been observed for mammalian proteins. To investigate the prevalence of PDZ/14-3-3 switching in signal transduction, we built a protein domain microarray that harbors PDZ domains and 14-3-3 proteins. We have used this microarray to interrogate the C-terminal tails of a small group of candidate proteins and identified ERBB4, PGHS2, and IRK1 (as well as E6 and PRMT5) as conforming to this signaling mode, suggesting that PDZ/14-3-3 switching may be a broad biological paradigm. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly.
- Author
-
Wei-Chih Tsai, Gayatri, Sitaram, Reineke, Lucas C., Sbardella, Gianluca, Bedford, Mark T., and Lloyd, Richard E.
- Subjects
- *
PROTEIN arginine methyltransferases , *DEMETHYLATION , *GRANULE cells , *NUCLEOPROTEINS , *RNA-binding proteins , *NUCLEATION - Abstract
Stress granules (SGs) are cytoplasmic condensates of stalled messenger ribonucleoprotein complexes (mRNPs) that form when eukaryotic cells encounter environmental stress. RNAbinding proteins are enriched for arginine methylation and facilitate SG assembly through interactions involving regions of low amino acid complexity. How methylation of specific RNAbinding proteins regulates RNA granule assembly has not been characterized. Here, we examined the potent SG-nucleating protein Ras-GAP SH3-binding protein 1 (G3BP1), and found that G3BP1 is differentially methylated on specific arginine residues by protein arginine methyltransferase (PRMT) 1 and PRMT5 in its RGG domain. Several genetic and biochemical interventions that increased methylation repressed SG assembly, whereas interventions that decreased methylation promoted SG assembly. Arsenite stress quickly and reversibly decreased asymmetric arginine methylation on G3BP1. These data indicate that arginine methylation in the RGG domain prevents large SG assembly and rapid demethylation is a novel signal that regulates SG formation. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. Increased Susceptibility to Skin Carcinogenesis Associated with a Spontaneous Mouse Mutation in the Palmitoyl Transferase Zdhhc13 Gene.
- Author
-
Perez, Carlos J, Mecklenburg, Lars, Jaubert, Jean, Martinez-Santamaria, Lucia, Iritani, Brian M, Espejo, Alexsandra, Napoli, Eleonora, Song, Gyu, del Río, Marcela, DiGiovanni, John, Giulivi, Cecilia, Bedford, Mark T, Dent, Sharon Y R, Wood, Richard D, Kusewitt, Donna F, Guénet, Jean-Louis, Conti, Claudio J, and Benavides, Fernando
- Subjects
- *
CARCINOGENESIS , *TRANSFERASES , *ACYLTRANSFERASES , *HYPERPLASIA , *KERATOSIS , *NONSENSE mutation - Abstract
Here we describe a spontaneous mutation in the Zdhhc13 (zinc finger, DHHC domain containing 13) gene (also called Hip14l), one of 24 genes encoding palmitoyl acyltransferase (PAT) enzymes in the mouse. This mutation (Zdhhc13luc) was identified as a nonsense base substitution, which results in a premature stop codon that generates a truncated form of the ZDHHC13 protein, representing a potential loss-of-function allele. Homozygous Zdhhc13luc/Zdhhc13luc mice developed generalized hypotrichosis, associated with abnormal hair cycle, epidermal and sebaceous gland hyperplasia, hyperkeratosis, and increased epidermal thickness. Increased keratinocyte proliferation and accelerated transit from basal to more differentiated layers were observed in mutant compared with wild-type (WT) epidermis in untreated skin and after short-term 12-O-tetradecanoyl-phorbol-13-acetate treatment and acute UVB exposure. Interestingly, this epidermal phenotype was associated with constitutive activation of NF-κB (RelA) and increased neutrophil recruitment and elastase activity. Furthermore, tumor multiplicity and malignant progression of papillomas after chemical skin carcinogenesis were significantly higher in mutant mice than WT littermates. To our knowledge, this is the first report of a protective role for PAT in skin carcinogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
24. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
- Author
-
Hadjikyriacou, Andrea, Yanzhong Yang, Espejo, Alexsandra, Bedford, Mark T., and Clarke, Steven G.
- Subjects
- *
PROTEIN arginine methyltransferases , *RNA splicing , *MESSENGER RNA , *MUTAGENESIS , *POLYPEPTIDES - Abstract
Human protein arginine methyltransferase (PRMT) 9 symmetrically dimethylates arginine residues on splicing factor SF3B2 (SAP145) and has been functionally linked to the regulation of alternative splicing of pre-mRNA. Site-directed mutagenesis studies on this enzyme and its substrate had revealed essential unique residues in the double E loop and the importance of the C-terminal duplicated methyltransferasedomain. In contrast towhathadbeen observed with other PRMTs and their physiological substrates, a peptide containing the methylatableArg-508ofSF3B2wasnot recognized by PRMT9 in vitro. Although amino acid substitutions of residues surrounding Arg-508 had no great effect on PRMT9 recognition of SF3B2, moving the arginine residue within this sequence abolished methylation.PRMT9andPRMT5are the only known mammalian enzymes capable of forming symmetric dimethylarginine (SDMA) residues as type II PRMTs. We demonstrate here that the specificity of these enzymes for their substrates is distinct and not redundant. The loss of PRMT5activity in mouse embryo fibroblasts results in almost complete loss of SDMA, suggesting that PRMT5 is the primary SDMA-forming enzyme in these cells. PRMT9, with its duplicated methyltransferase domain and conserved sequence in the double E loop, appears to have a unique structure and specificity among PRMTs for methylating SF3B2 and potentially other polypeptides. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. Methyllysine Reader Plant Homeodomain (PHD) Finger Protein 20-like 1 (PHF20L1) Antagonizes DNA (Cytosine-5) Methyltransferase 1 (DNMT1) Proteasomal Degradation.
- Author
-
Estève, Pierre-Olivier, Terragni, Jolyon, Deepti, Kanneganti, Hang Gyeong Chin, Nan Dai, Espejo, Alexsandra, Corrêa Jr., Ivan R., Bedford, Mark T., and Pradhan, Sriharsa
- Subjects
- *
HOMEOBOX proteins , *METHYLTRANSFERASES , *CYTOSINE , *LYSINE , *DNA methylation , *CELL proliferation - Abstract
Inheritance of DNA cytosine methylation pattern during successive cell division is mediated by maintenance DNA (cytosine-5) methyltransferase 1 (DNMT1). Lysine 142 of DNMT1 is methylated by the SET domain containing lysine methyltransferase 7 (SET7), leading to its degradation by proteasome. Here we show that PHD finger protein 20-like 1 (PHF20L1) regulates DNMT1 turnover in mammalian cells. Malignant brain tumor (MBT) domain of PHF20L1 binds to monomethylated lysine 142 on DNMT1 (DNMT1K142me1) and colocalizes at the perinucleolar space in a SET7-dependent manner. PHF20L1 knockdown by siRNA resulted in decreased amounts of DNMT1 on chromatin. Ubiquitination of DNMT1K142me1 was abolished by overexpression of PHF20L1, suggesting that its binding may block proteasomal degradation of DNMT1K142me1. Conversely, siRNA-mediated knockdown of PHF20L1 or incubation of a small molecule MBT domain binding inhibitor in cultured cells accelerated the proteasomal degradation of DNMT1. These results demonstrate that the MBT domain of PHF20L1 reads and controls enzyme levels of methylatedDNMT1 in cells, thus representing a novel antagonist of DNMT1 degradation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
26. Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions.
- Author
-
You Feng, Maity, Ranjan, Whitelegge, Julian P., Hadjikyriacou, Andrea, Ziwei Li, Zurita-Lopez, Cecilia, Al-Hadid, Qais, Clark, Amander T., Bedford, Mark T., Masson, Jean-Yves, and Clarke, Steven G.
- Subjects
- *
AMINO acids , *ARGININE , *ENZYMES , *GENETIC mutation , *BASIC proteins - Abstract
The mammalian protein arginine methyltransferase 7 (PRMT7) has been implicated in roles of transcriptional regulation, DNA damage repair, RNA splicing, cell differentiation, and metastasis. However, the type of reaction that it catalyzes and its substrate specificity remain controversial. In this study, we purified a recombinant mouse PRMT7 expressed in insect cells that demonstrates a robust methyltransferase activity. Using a variety of substrates, we demonstrate that the enzyme only catalyzes the formation of ω-monomethylarginine residues, and we confirm its activity as the prototype type III protein arginine methyltransferase. This enzyme is active on all recombinant human core histones, but histone H2B is a highly preferred substrate. Analysis of the specific methylation sites within intact histone H2B and within H2B and H4 peptides revealed novel post-translational modification sites and a unique specificity of PRMT7 for methylating arginine residues in lysine- and arginine-rich regions. We demonstrate that a prominent substrate recognition motif consists of a pair of arginine residues separated by one residue (RXR motif). These findings will significantly accelerate substrate profile analysis, biological function study, and inhibitor discovery for PRMT7. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
27. Loss of the Methyl Lysine Effector Protein PHF20 Impacts the Expression of Genes Regulated by the Lysine Acetyltransferase MOF.
- Author
-
Badeaux, Aimee I., Yanzhong Yang, Kim Cardenas, Vemulapalli, Vidyasiri, Kaifu Chen, Kusewitt, Donna, Richie, Ellen, Wei Li, and Bedford, Mark T.
- Subjects
- *
GENE expression , *LYSINE , *PHENOTYPES , *ACETYLTRANSFERASES , *METHYLATION - Abstract
In epigenetic signaling pathways, histone tails are heavily modified, resulting in the recruitment of effector molecules that can influence transcription. One such molecule, plant homeodomain finger protein 20 (PHF20), uses a Tudor domain to read dimethyl lysine residues and is a known component of the MOF(male absent on the first) histone acetyltransferase protein complex, suggesting it plays a role in the cross-talk between lysine methylation and histone acetylation. We sought to investigate the biological role of PHF20 by generating a knockout mouse. Without PHF20, mice die shortly after birth and display a wide variety of phenotypes within the skeletal and hematopoietic systems. Mechanistically, PHF20 is not required for maintaining the global H4K16 acetylation levels or locus specific histone acetylation but instead works downstream in transcriptional regulation of MOF target genes. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
28. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1
- Author
-
Bissinger, Elisabeth-Maria, Heinke, Ralf, Spannhoff, Astrid, Eberlin, Adrien, Metzger, Eric, Cura, Vincent, Hassenboehler, Pierre, Cavarelli, Jean, Schüle, Roland, Bedford, Mark T., Sippl, Wolfgang, and Jung, Manfred
- Subjects
- *
SULFONAMIDES , *DRUG derivatives , *METHYLTRANSFERASES , *ARGININE , *ENZYME inhibitors , *METHYLATION , *EPIGENESIS , *LEPROSTATIC agents - Abstract
Abstract: Arginine methylation is an epigenetic modification that receives increasing interest as it plays an important role in several diseases. This is especially true for hormone-dependent cancer, seeing that histone methylation by arginine methyltransferase I (PRMT1) is involved in the activation of sexual hormone receptors. Therefore, PRMT inhibitors are potential drugs and interesting tools for cell biology. A dapsone derivative called allantodapsone previously identified by our group served as a lead structure for inhibitor synthesis. Acylated derivatives of p-aminobenzenesulfonamides and the antilepra drug dapsone were identified as new inhibitors of PRMT1 by in vitro testing. The bis-chloroacetyl amide of dapsone selectively inhibited human PRMT1 in the low micromolar region and was selective for PRMT1 as compared to the arginine methyltransferase CARM1 and the lysine methyltransferase Set7/9. It showed anticancer activity on MCF7a and LNCaP cells and blocked androgen dependent transcription specifically in a reporter gene system. Likewise, a transcriptional block was also demonstrated in LNCaP cells using quantitative RT-PCR on the mRNA of androgen dependent genes. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
29. Protein-arginine Methyltransferase 1 (PRMT1) Methylates Ash2L, a Shared Component of Mammalian Histone H3K4 Methyltransferase Complexes.
- Author
-
Butler, Jill S., Zurita-Lopez, Cecilia I., Clarke, Steven G., Bedford, Mark T., and Dent, Sharon Y. R.
- Subjects
- *
HISTONES , *MULTIENZYME complexes , *ENZYMATIC analysis , *METHYLTRANSFERASES , *GENE expression - Abstract
Multiple enzymes and enzymatic complexes coordinately regulate the addition and removal of post-translational modifications on histone proteins. The oncoprotein Ash2L is a component of the mixed lineage leukemia (MLL) family members 1-4, Setd 1A, and Setd 1B mammalian histone H3K4 methyltransferase complexes and is essential to maintain global trimethylation of histone H3K4. However, regulation of these complexes at the level of expression and activity remains poorly understood. In this report, we demonstrate that Ash2L is methylated on arginine residues both in vitro and in cells. We found that both protein-arginine methyltransferases 1 and S methylate Arg-296 within Ash2L. These findings are the first to demonstrate that post-translational modifications occur on the Ash2L protein and provide a novel example of cross-talk between chromatin- modifying enzyme complexes. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
30. Enzymatic Activity Is Required for the in Vivo Functions of CARM1.
- Author
-
Daehoon Kim, Jaeho Lee, Donghang Cheng, Jia Li, Carter, Carla, Richie, Ellen, and Bedford, Mark T.
- Subjects
- *
PROTEIN arginine methyltransferases , *TRANSCRIPTION factors , *PROTEIN research , *LABORATORY mice , *FAT cells , *TRANSFER RNA , *FLOW cytometry - Abstract
CARM1 is one of nine protein arginine methyltransferases that methylate arginine residues in proteins. CARM1 is recruited by many different transcription factors as a positive regulator. Gene targeting of CARM1 in mice has been performed, and knock-out mice, which are smaller than their wild-type littermates, die just after birth. It has been proposed that CARM1 has functions that are independent of its enzymatic activity. Indeed, CARM1 is found to interact with a number of proteins and may have a scaffolding function in this context. However, CARM1 methylates histone H3, PABP1, AIB1, and a number of splicing factors, which strongly suggests that its impact on transcription and splicing is primarily through its ability to modify these substrates. To unequivocally establish the importance of CARM1 enzymatic activity in vivo, we generated an enzyme-dead knock-in of this protein arginine methyltransferase. We determined that knock-in cells and mice have defects similar to those seen in their knock-out counterparts with respect to the time of embryo lethality, T cell development, adipocyte differentiation, and transcriptional coactivator activity. CARM1 requires its enzymatic activity for all of its known cellular functions. Thus, small molecule inhibitors of CARM1 will incapacitate all of the enzyme's cellular functions. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
31. Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1.
- Author
-
Ying Xie, Sui Ke, Nengtai Ouyang, Jinhan He, Wen Xie, Bedford, Mark T., and Tian, Yanan
- Subjects
- *
PREGNANE , *TRANSCRIPTION factors , *GENE expression , *METHYLTRANSFERASES , *GENETIC regulation , *LIGAND binding (Biochemistry) , *ARGININE - Abstract
Pregnane X receptor (PXR) is a ligand-dependent transcription factor, regulating gene expression of enzymes and transporters involved in xenobiotic/drug metabolism. Here, we report that protein arginine methyltransferase 1 (PRMT1) is required for the transcriptional activity of PXR. PRMT1 regulates expression of numerous genes, including nuclear receptor-regulated transcription, through methylating histone and non-histone proteins. Co-immunoprecipitation and histone methyltransferase assays revealed that PRMT1 is a major histone methyltransferase associated with PXR. The PXR ligand-binding domain is responsible for PXR-PRMT1 interaction as determined by mammalian two-hybrid and glutathione S-transferase (GST) pull-down assays. The chromatin immunoprecipitation (ChIP) assay showed that PRMT1 was recruited to the regulatory region of the PXR target gene cytochrome P450 3A4 (CYP3A4), with a concomitant methylation of arginine 3 of histone H4, in response to the PXR agonist rifampicin. In mammalian cells, small interfering RNA (siRNA) knockdown and gene deletion of PRMT1 greatly diminished the transcriptional activity of PXR, suggesting an indispensable role of PRMT1 in PXR-regulated gene expression. Interestingly, PXR appears to have a reciprocal effect on the PRMT1 functions by regulating its cellular compartmentalization as well as its substrate specificity. Taken together, these results demonstrated mutual interactions and functional interplays between PXR and PRMT1, and this interaction may be important for the epigenetics of PXR-regulated gene expression. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
32. Arginine Methylation of the Histone H3 Tail Impedes Effector Binding.
- Author
-
Iberg, Aimee N., Espejo, Alexsandra, Donghang Cheng, Daehoon Kim, Michaud-Levesque, Jonathan, Richard, Stephane, and Bedford, Mark T.
- Subjects
- *
HISTONES , *ARGININE , *METHYLATION , *BASIC proteins , *GENETIC translation , *GENETIC regulation , *CHROMATIN - Abstract
Histone tail post-translational modification results in changes in cellular processes, either by generating or blocking docking sites for histone code readers or by altering the higher order chromatin structure. H3K4me3 is known to mark the promoter regions of active transcription. Proteins bind H3K4 in a methyl-dependent manner and aid in the recruitment of histone-remodeling enzymes and transcriptional cofactors. The H3K4me3 binders harbor methyl-specific chromatin binding domains, including plant homeodomain, Chromo, and tudor domains. Structural analysis of the plant homeodomains present in effector proteins, as well as the WD40 repeats of WDR5, reveals critical contacts between residues in these domains and H3R2. The intimate contact between H3R2 and these domain types leads to the hypothesis that methylation of this arginine residue antagonizes the binding of effector proteins to the N-terminal tail of H3. Here we show that H3 tail binding effector proteins are indeed sensitive to H3R2 methylation and that PRMT6, not CARM1/PRMT4, is the primary methyltransferase acting on this site. We have tested the expression of a select group of H3K4 effector-regulated genes in PRMT6 knockdown cells and found that their levels are altered. Thus, PRMT6 methylates H3R2 and is a negative regulator of N-terminal H3 tail binding. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
33. Regulation of Protein Arginine Methyltransferase 8 (PRMT8) Activity by Its N-terminal Domain.
- Author
-
Sayegh, Joyce, Webb, Kristofor, Donghang Cheng, Bedford, Mark T., and Clarke, Steven G.
- Subjects
- *
ARGININE , *METHYLTRANSFERASES , *ENZYMES , *CELL membranes , *AMINO acids , *RECOMBINANT proteins - Abstract
Human protein arginine methyltransferase PRMT8 has been recently described as a type I enzyme in brain that is localized to the plasma membrane by N-terminal myristoylation. The amino acid sequence of human PRMT8 is almost 80% identical to human PRMT1, the major protein arginine methyltransferase activity in mammalian cells. However, the activity of a recombinant PRMT8 GST fusion protein toward methyl-accepting substrates is much lower than that of a GST fusion of PRMT1. We show here that both His-tagged and GST fusion species lacking the initial 60 amino acid residues of PRMT8 have enhanced enzymatic activity, suggesting that the N-terminal domain may regulate PRMT8 activity. This conclusion is supported by limited proteolysis experiments showing an increase in the activity of the digested full-length protein, consistent with the loss of the N-terminal domain. In contrast, the activity of the N-terminal truncated protein was slightly diminished by limited proteolysis. Significantly, we detect automethylation at two sites in the N-terminal domain, as well as binding sites for SH3 domain-containing proteins. We suggest that the N-terminal domain may function as an autoregulator that may be displaced by interaction with one or more physiological inducers. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
34. Ribosomal Protein rpS2 Is Hypomethylated in PRMT3-deficient Mice.
- Author
-
Swiercz, Rafal, Donqhang Cheng, Daehoon Kim, and Bedford, Mark T.
- Subjects
- *
ARGININE , *CYTOPLASM , *RIBOSOMES , *ORGANELLES , *NUCLEOPROTEINS - Abstract
PRMT3 is a type I arginine methyltransferase that resides in the cytoplasm. A large proportion of this cystosolic PRMT3 is found associated with ribosomes. It is tethered to the ribosomes through its interaction with rpS2, which is also its substrate. Here we show that mouse embryos with a targeted disruption of PRMT3 are small in size but survive after birth and attain a normal size in adulthood, thus displaying Minute-like characteristics. The ribosome protein rpS2 is hypomethylated in the absence of PRMT3, demonstrating that it is a bonafide, in vivo PRMT3 substrate that cannot be modified by other PRMTs. Finally, the levels 40 S, 60 S, and 80 S monosomes and polyribosomes are unaffected by the loss of PRMT3, but there are additional as yet unidentified proteins that co-fractionate with ribosomes that are also dedicated PRMT3 substrates. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
35. Proteome-wide Analysis in Saccharomyces cerevisiae Identifies Several PHD Fingers as Novel Direct and Selective Binding Modules of Histone H3 Methylated at Either Lysine 4 or Lysine 36.
- Author
-
Xiaobing Shi, Kachirskaia, Ioulia, Walter, Kay L., Kuo, Jen-Hao A., Lake, Aimee, Davrazou, Foteini, Chan, Steve M., Martin, David G. E., Fingerman, Ian M., Briggs, Scott D., Howe, Leann, Utz, Paul J., Kutateladze, Tatiana G., Lugovskoy, Alexey A., Bedford, Mark T., and Gozani, Or
- Subjects
- *
PROTEOLYTIC enzymes , *LYSINE , *SACCHAROMYCES cerevisiae , *HISTONES , *CHROMATIN - Abstract
The PHD finger motif is a signature chromatin-associated motif that is found throughout eukaryotic proteomes. Here we have determined the histone methyl-lysine binding activity of the PHD fingers present within the Saccharomyces cerevisiae proteome. We provide evidence on the genomic scale that PHD fingers constitute a general class of effector modules for histone H3 trimethylated at lysine 4 (H3K4me3) and histone H3 trimethylated at lysine 36 (H3K36me3). Structural modeling of PHD fingers demonstrates a conserved mechanism for recognizing the trimethyl moiety and provides insight into the molecular basis of affinity for the different methyl-histone ligands. Together, our study suggests that a common function for PHD fingers is to transduce methyl-lysine events and sheds light on how a single histone modification can be linked to multiple biological outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
36. The AT-hook of the Chromatin Architectural Transcription Factor High Mobility Group A1a Is Arginine-methylated by Protein Arginine Methyltransferase 6.
- Author
-
Sgarra, Riccardo, Jaeho Lee, Tessari, Michela A., Altamura, Sandro, SpoIaore, Barbara, Giancotti, Vincenzo, Bedford, Mark T., and ManfioIetti, Guidalberto
- Subjects
- *
CHROMATIN , *NF-kappa B , *TRANSCRIPTION factors , *METHYLTRANSFERASES , *ARGININE , *UBIQUITIN , *METHYLATION - Abstract
The HMGA1a protein belongs to the high mobility group A (HMGA) family of architectural nuclear factors, a group of proteins that plays an important role in chromatin dynamics. HMGA proteins are multifunctional factors that associate both with DNA and nuclear proteins that have been involved in several nuclear processes, such as transcriptional regulation, viral integration, DNA repair, RNA processing, and chromatin remodeling. The activity of HMGA proteins is finely modulated by a variety of post-translational modifications. Arginine methylation was recently demonstrated to occur on HMGA1a protein, and it correlates with the apoptotic process and neoplastic progression. Methyltransferases responsible for these modifications are unknown. Here we show that the protein arginine methyltransferase PRMT6 specifically methylates HMGA1a protein both in vitro and in vivo. By mass spectrometry, the sites of methylation were unambiguously mapped to Arg57 and Arg59, two residues which are embedded in the second AT-hook, a region critical for both protein-DNA and protein-protein interactions and whose modification may cause profound alterations in the HMGA network. The in vivo association of HMGA and PRMT6 place this yet functionally uncharacterized methyltransferase in the well established functional context of the chromatin structure organization. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
37. PRMT8, a New Membrane-bound Tissue-specific Member of the Protein Arginine Methyltransferase Family.
- Author
-
Jaeho Lee, Sayegh, Joyce, Daniel, Jeremy, Clarke, Steven, and Bedford, Mark T.
- Subjects
- *
ARGININE , *PROTEINS , *METHYLTRANSFERASES , *TISSUES , *DNA repair , *GLYCINE , *CELL membranes - Abstract
Protein arginine methylation is a common post-translational modification that has been implicated in signal transduction, RNA processing, transcriptional regulation, and DNA repair. A search of the human genome for additional members of the protein arginine N-methyltransferase (PRMT) family of enzymes has identified a gene on chromosome 12 that we have termed PRMT8. This novel enzyme is most closely related to PRMT1, although it has a distinctive N-terminal region. The unique N-terminal end harbors a myristoylation motif, and we have shown here that PRMT8 is indeed modified by the attachment of a myristate to the glycine residue after the initiator methionine. The myristoylation of PRMT8 results in its association with the plasma membrane. The second singular property of PRMT8 is its tissue-specific expression pattern; it is largely expressed in the brain. A glutathione S-transferase fusion protein of PRMT8 has type I PRMT activity, catalyzing the formation of ω-NG-monomethylated and asymmetrically ω-NG,NG-dimethylated arginine residues on a recombinant glycine- and arginine-rich substrate. PRMT8 is thus an active arginine methyltransferase that is membrane-associated and tissue-specific, two firsts for this family of enzymes. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
38. Loss of CARM1 Results in Hypomethylation of Thymocyte Cyclic AMP-regulated Phosphoprotein and Deregulated Early T Cell Development.
- Author
-
Jeesun Kim, Jaeho Lee, Neelu Yadav, Qi Wu, Carter, Carla, Richard, Stéphane, Richie, Ellen, and Bedford, Mark T.
- Subjects
- *
PHOSPHOPROTEINS , *T cells , *CYCLIC adenylic acid , *AMINO acids , *ARGININE , *GENETIC transcription - Abstract
The coactivator-associated arginine methyltransferase, CARM1, is a positive regulator of transcription. Using high density protein arrays, we have previously identified in vitro substrates for CARM1. One of these substrates, TARPP (thymocyte cyclic AMP-regulated phosphoprotein), is expressed specifically in immature thymocytes. Here, we have demonstrated that TARPP is argtnine-methylated at a single residue, Arg650, both in vitro and in vivo. In addition, recombinant TARPP is not methylated by extracts from Carml-/- cells, indicating that there is no redundancy in this pathway. We show that thymi from Carml-/- embryos (E18.5) have a 5-10fold reduction in cellularity compared with wild type littermates. Flow cytometric analysis of thymocytes revealed a decrease in the relative proportion of double negative thymocytes in Carml-/- embryos because of a partial developmental arrest in the earliest thymocyte progenitor subset. These results demonstrate that CARM1 plays a significant role in promoting the differentiation of early thymocyte progenitors, possibly through its direct action on TARPP. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
39. Small Molecule Regulators of Protein Arginine Methyltransferases.
- Author
-
Cheng, Donghong, Yadav, Neelu, King, Randall W., Swanson, Maurice S., Weinstein, Edward J., and Bedford, Mark t.
- Subjects
- *
MOLECULES , *ARGININE , *METHYLTRANSFERASES , *METHIONINE , *ENZYMES , *LYSINE , *NUCLEAR receptors (Biochemistry) , *BINDING sites - Abstract
Here we report the identification of small molecules that specifically inhibit protein arginine N-methyltransferase (PRMT) activity. PRMTs are a family of proteins that either monomethylate or dimethylate the guanidino nitrogen atoms of arginine side chains. This common post-translational modification is implicated in protein trafficking, signal transduction, and transcriptional regulation. Most methyltransferases use the methyl donor, S-adenosyl-L-methionine (AdoMet), as a cofactor. Current methyltransferase inhibitors display limited specificity, indiscriminately targeting all enzymes that use AdoMet. In this screen we have identified a primary compound, AMI-1, that specifically inhibits arginine, but not lysine, methyltransferase activity in vitro and does not compete for the AdoMet binding site. Furthermore, AMI-1 prevents in vivo arginine methylation of cellular proteins and can modulate nuclear receptor-regulated transcription from estrogen and androgen response elements, thus operating as a brake on certain hormone actions. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
40. Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses.
- Author
-
Prasanth, K. Reddisiva, Hirano, Minato, Fagg, W. Samuel, McAnarney, Eileen T., Shan, Chao, Xie, Xuping, Hage, Adam, Pietzsch, Colette A., Bukreyev, Alexander, Rajsbaum, Ricardo, Shi, Pei-Yong, Bedford, Mark T., Bradrick, Shelton S., Menachery, Vineet, and Garcia-Blanco, Mariano A.
- Subjects
- *
EBOLA virus , *INFLUENZA viruses , *YELLOW fever , *DNA topoisomerase I , *VIRAL genomes , *RNA viruses , *SARS-CoV-2 , *DENGUE viruses - Abstract
Based on genome-scale loss-of-function screens we discovered that Topoisomerase III-β (TOP3B), a human topoisomerase that acts on DNA and RNA, is required for yellow fever virus and dengue virus-2 replication. Remarkably, we found that TOP3B is required for efficient replication of all positive-sense-single stranded RNA viruses tested, including SARS-CoV-2. While there are no drugs that specifically inhibit this topoisomerase, we posit that TOP3B is an attractive anti-viral target. • Topoisomerase III-ß (TOP3B) is a host factor for all single stranded positive strand RNA viruses. • TOP3B is not a host factor for Ebola and influenza viruses, which are negative strand RNA viruses. • TOP3B acts directly on the viral genome of DENV2. • TOP3B could be a target for antiviral development. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.